Merck swings to 3Q loss on big charge but raises forecast
Lower sales for multiple medicines and a whopping charge for a big collaboration in cancer drugs drove Merck & Co. to a third-quarter loss of $56 million.
from Biotech News
Lower sales for multiple medicines and a whopping charge for a big collaboration in cancer drugs drove Merck & Co. to a third-quarter loss of $56 million.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments